Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol.

ABSTRACT:

SUBMITTER: Attard G 

PROVIDER: S-EPMC7616864 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature